PTC Therapeutics (PTCT)
(Delayed Data from NSDQ)
$25.21 USD
-0.20 (-0.79%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $25.20 -0.01 (-0.04%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth B Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
04/25/2024
Time: AMC |
3/2024 | $-1.31 | 13.74% |
Earnings Summary
For their last quarter, PTC Therapeutics (PTCT) reported earnings of -$0.24 per share, missing the Zacks Consensus Estimate of $0.29 per share. This reflects a negative earnings surprise of 182.76%. Look out for PTCT's next earnings release on April 25, 2024. For the next earning release, we expect the company to report earnings of -$1.31 per share, reflecting a year-over-year increase of 30.32%.
Earnings History
Price & Consensus
Zacks News for PTCT
Biotech Stock Roundup: GERN, CRNX Gain on Updates, BMY's CAR T Cell Therapy News & More
PTCT: What are Zacks experts saying now?
Zacks Private Portfolio Services